France
SpineGuard is a French innovative medical company founded in 2009 with a mission to make spine surgery safer. The company is dedicated to the deployment and adoption of its proprietary DSG® (Dynamic Surgical Guidance) technology, which provides real-time feedback to secure and streamline skeletal implant placement. The technology has applications in various skeletal procedures, from bone drilling instruments to the automated placement of bone implants, making SpineGuard uniquely positioned to revolutionize orthopedic robotic surgery.
SpineGuard's flagship product, the PediGuard probes, are handheld tools designed to assist spine surgeons in accurately placing pedicle screws. These devices integrate the DSG technology, providing audio and visual feedback to alert surgeons about changes in conductivity during the drilling process, without the need for X-Ray imaging. This innovation has been used in over 90,000 spinal procedures worldwide, catering to patients of all ages and conditions, from deformity corrections in pediatric cases to internal fixation in degenerative diseases among adults.
With a focus on patient safety and clinical efficacy, SpineGuard has accumulated 24 major Peer-Reviewed publications validating the efficacy of its technology. The company recently received a €500.00K post-IPO equity investment on 16 May 2023 from XinRong Medical, underscoring increasing investor confidence in its potential to address the clinical needs associated with safe and accurate pedicle screw placement.
SpineGuard operates at the intersection of Health Care, Information Technology, and Medical Devices, and its commitment to technological innovation and patient outcomes positions it as a compelling player in the evolving landscape of spine surgery and orthopedic interventions.
